Reginald Frye Pharm.D., Ph.D., FCCP
Dr. Frye is a Professor and Chair for the Department of Pharmacotherapy and Translational Research College of Pharmacy. He received a B.S. in Biology from Oglethorpe University, a Pharm.D. from Mercer University School of Pharmacy, and a Ph.D. in Clinical Pharmaceutical Sciences from the University of Pittsburgh School of Pharmacy. After completing graduate work, Dr. Frye remained on faculty at the University of Pittsburgh from 1995 until 2003, being promoted to Associate Professor with tenure in 2002. He joined the faculty at the University of Florida in July 2003 and in July 2012, he was promoted to Professor.
Division of Community-Based Pharmacotherapy
Michelle Z Farland Pharm.D., BCPS, CDE
Dr. Farland received her Doctor of Pharmacy degree from the University of Pittsburgh School of Pharmacy in 2005. She completed a pharmacy practice residency at Shands Jacksonville Medical Center (now UF Health at Jacksonville) in Jacksonville, Florida and a specialty residency in Ambulatory care/Primary care at the Virginia Commonwealth University Medical College of Virginia Hospitals in Richmond, Virginia. Dr. Farland joined the faculty of the University of Tennessee Health Science Center College of Pharmacy in 2007 and was promoted to Associate Professor in 2012. She then joined the faculty of the University of Florida in 2015.
She currently serves as the Division Head of Community-Based Pharmacotherapy, which encompasses faculty practicing in a variety of outpatient practice models. Her educational research focuses on outcomes of team-based learning and personal and professional development. Dr. Farland has been recognized by the American College of Clinical Pharmacy with the 2012 New Educator Award, by the Team Based Learning Collaborative (TBLC) in 2016 as a team-based learning consultant-trainer, and by the American Association of Colleges of Pharmacy (AACP) in 2017 as an Emerging Teaching Scholar. She also received an honorable mention for the AACP Innovations in Teaching Award in 2019.
Dr. Farland is the president of the Team-Based Learning Collaborative (TBLC), and is a member of the American Association of Colleges of Pharmacy (AACP), American College of Clinical Pharmacy (ACCP), and Phi Lambda Sigma Pharmacy Leadership Society (PLS). Dr. Farland has served as a national speaker in the areas of diabetes, team-based learning, collaborative learning teams, and situational judgement tests.
Meghan J Arwood Pharm.D., M.S., BCPS
Meghan Arwood, PharmD, MS, received her BS and PharmD degrees from the University of Florida, and she completed a PGY1 Pharmacy Practice Residency at Holmes Regional Medical Center in Melbourne, Florida. Following residency, she started a fellowship in translational pharmacogenomics at the University of Illinois at Chicago and completed it at the University of Florida. Arwood received her MS degree in Clinical and Translational Science from the University of Illinois at Chicago. Her thesis research focused on transcriptomic predictors of pulmonary hypertension development in heart failure patients. Arwood joined the University of Florida College of Pharmacy as a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research in 2017. In her role, she supports the implementation of pharmacogenomics through UF Health’s Precision Medicine Program. Arwood directs a pharmacogenetics consult clinic within the primary care setting and is a board-certified pharmacotherapy specialist. Her research interests include cardiopulmonary pharmacogenomics, clinical implementation of pharmacogenomics, and RNA-sequencing.
Teresa Cavanaugh Pharm.D., BCPS
Teresa Cavanaugh received her Doctor of Pharmacy Degree from the University of Cincinnati College of Pharmacy in 2006. Upon graduation, she completed a pharmacy practice residency at The University Hospital in Cincinnati, which solidified her interest in practice-based research with transplant patients. She then completed a two-year fellowship in health outcomes research with a focus on liver transplantation. During her fellowship, she received board certification as a pharmacotherapy specialist, and a Master of Science degree in pharmacy administration with an emphasis on health outcomes research. Dr. Cavanaugh joined the faculty of the University of Cincinnati College of Pharmacy in 2009. Her practice site was an ambulatory liver transplant clinic. Dr. Cavanaugh was actively involved in both the American Society of Health-System Pharmacists where she served as Vice Chair and Chair of the Commission on Affiliate Relations and with the Ohio Society of Health-System Services where she served two terms as division director for Organizational Affairs and was elected president in 2014. In 2016, Dr. Cavanaugh became introductory pharmacy practice experiences coordinator and the co-curricular activities coordinator. She was promoted to clinical associate professor of pharmacy practice in August 2017. Her current research interests involve student mental health and identifying characteristics that lead to success in pharmacy school.
Emily J Cicali Pharm.D.
Emily Cicali, Pharm.D., received her Doctor of Pharmacy degree from Philadelphia College of Pharmacy, University of the Sciences in 2015. She then completed a Pharmacy Practice Residency at Tabula Rasa HealthCare in Geriatric Personalized Medicine. After her residency, she was hired to work Tabula Rasa HealthCare at as a Research Pharmacist, as well as adjunct faculty at the Philadelphia College of Pharmacy, focusing on clinical pharmacokinetics and pharmacogenomics implementation. In 2017 she decided to fully transition to academia, which led to her completion of a fellowship in pharmacogenomics at the University of Florida. Cicali is now a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research. Her clinical practice is within the UF Health Personalized Medicine Program and her research interests include clinical implementation of pharmacogenomics as well as further understanding the role of phenoconversion for optimal medication safety.
Kelsey Cook Pharm.D., BCPS
Kelsey Cook, Pharm.D., received her B.S. from the University of Maryland and her Pharm.D. from the University of North Carolina. She completed a PGY1 Pharmacy Practice Residency at Dell Seton Medical Center in Austin, Texas and a PGY2 Clinical Pharmacogenomics Residency at the University of Florida in Gainesville, Florida. Dr. Cook joined the University of Florida College of Pharmacy, Jacksonville campus as a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research in 2019. In her role, she supports the implementation of pharmacogenomics at Nemour’s Childrens Specialty Care. Dr. Cook is a board-certified pharmacotherapy specialist. Her research interests include clinical implementation of pharmacogenomics and pharmacogenomics in pediatrics.
Stacey Curtis Pharm.D.
Stacey Curtis says her mantra lies within the Ralph Waldo Emerson quote, “The purpose of life is not to be happy. It is to be useful, to be honorable, to be compassionate, to have it make some difference that you have lived and lived well…” She completes the quote with her own ending, “then happiness will follow!” Curtis displays her love of life and energy in the various roles she plays within the college. Currently, she serves as the Course Coordinator for Professional Practice Skills Lab, Community Introductory Pharmacy Practice Experience, and Advanced Topics in Community Pharmacy. The latter, an elective she created herself, combines two of her life passions: student development through teaching and community pharmacy practice. Additionally she serves as Course Co-Coordinator for Principles of Systems-Based Practice and Pharmacy Management.
Outside of the classroom, she was appointed by Dean Julie Johnson to serve on the Recruitment, Admissions, and Retention Task Force and is a member of the Admissions Committee. She serves as a Brand Ambassador as well as the 2017-2018 Faculty Delegate for the American Association of Colleges of Pharmacy (AACP). To ensure her connections with students outside of the classroom, Curtis is the Faculty Advisor for National Community Pharmacists Association (NCPA), Gator Pharmacy Wellness (GPW), and Christian Pharmacists Fellowship International (CPFI). Faith, family, and friends provide a solid foundation and balance for Curtis on a day-to-day basis. She is a traveling nomad at heart. She loves spending quality time with her husband and 3 children, outdoor activities and mentoring professional pharmacy students.
Prior to her current endeavors, Curtis worked in the Office of Experiential Programs serving as a Regional Coordinator for the Gainesville, Panhandle, and out-of-state regions (5 years), the Lead Regional Coordinator (4 years), and as the Assistant Director (1 year). The college deems Curtis a “Community Pharmacy Expert” given her 20+ years of experience where she has had many roles including Staff Pharmacist, Pharmacy Manager, Pharmacist Trainer, Pharmacy Recruiter, Pharmacy Intern Coordinator, and of course Preceptor for many pharmacy students.
Christina E DeRemer Pharm.D., BCPS, BCACP, FASHP
Christina DeRemer received her Doctor of Pharmacy degree from the University of the Sciences, Philadelphia College of Pharmacy, in Philadelphia. After graduation, she completed a Pharmacy Practice Residency and an Ambulatory Care Pharmacy Specialty Residency at the University of Pittsburgh Medical Center. Following a year at Harbor Hospital in Baltimore, DeRemer began her career as a clinical specialist in primary care at the Augusta University Medical Center in Augusta, Georgia (formerly Medical College of Georgia Health Inc.) Her clinical practice responsibilities included the adult inpatient internal medicine/hospitalist services and the pharmacist-managed ambulatory care anticoagulation clinic, where she precepted both pharmacy residents and students. She served as the pharmacy supervisor for the medicine team and also held an appointment as adjunct clinical associate professor with the University of Georgia College of Pharmacy. She functioned as the educational site coordinator for IPPE/APPE pharmacy students, and precepted clinical experiences for internal medicine, institutional, precepting, and ambulatory for both students and pharmacy residents. She was recognized twice by the UGA College of Pharmacy as the Preceptor of the Year. In September 2017, she joined the University of Florida College of Pharmacy as a clinical associate professor within the department of pharmacotherapy and translational research and holds a practice at UF Health Family Medicine Clinic in Old Town.
Eric A Dietrich Pharm.D.
Dr. Dietrich is a Clinical Assistant Professor within the Department of Pharmacotherapy and Translational Research. His work involves managing an Anticoagulation Clinic at UF Health Internal Medicine at Tower Hill monitoring warfarin as well as DOACs in addition to a multidisciplinary transitions of care clinic for patients with a recent acute myocardial infarction. Dr. Dietrich’s research interests include interventions aimed at reducing anticoagulation, hypertension, cardiovascular disease, and pharmacy billing and reimbursement for clinical services in collaborative clinical environments. Dr. Dietrich is a Board Certified Ambulatory Care Pharmacist as well as a Certified Professional Coder. Dr. Dietrich’s teaching focuses on anticoagulation and cardiovascular disease and he is the Program Director for the UF College of Pharmacy PGY2 Specialty Residency in Ambulatory Care. Dr. Dietrich’s wife, Nicole, is a pharmacist at the VA.
Eric F Egelund Ph.D., Pharm.D.
After completing his Pharm.D. at the University of Florida College of Pharmacy, Dr. Egelund enrolled in the Ph.D. program at the University of Florida. Dr. Egelund completed his graduate studies in the Department of Pharmacotherapy and Translational Research under the mentorship of Dr. Charles Peloquin, director of the Infectious Disease Pharmacokinetics Laboratory (IDPL) in Gainesville. Currently Dr. Egelund is a Clinical Assistant Professor at the College of Pharmacy’s Jacksonville campus. In addition to this role Dr. Egelund works part-time at Walgreens and volunteers at HIV clinics when time permits.
John Gums Pharm.D., FCCP
Dr. Gums is a Professor of Pharmacy and Medicine in the Departments of Pharmacotherapy and Translational Research and Community Health and Family Medicine at the University of Florida. Additionally, he holds the title of Associate Dean for Clinical and Administrative Affairs in the College of Pharmacy and Director of Clinical Research in Family Medicine at the University of Florida. He received his undergraduate degree in pharmacy from the University of Wisconsin and his Doctor of Pharmacy degree from the Medical University of South Carolina. Subsequently, he completed a fellowship in Family Medicine at the Medical University of South Carolina. Dr. Gums joined the faculty at the University of Florida in 1985, and is actively involved in teaching in the colleges of Pharmacy and Medicine. He has received the Faculty Recognition Award from the College of Pharmacy and twice was selected as Teacher of the Year by the University of Florida, Department of Family Medicine.
Shannon A Miller Pharm.D., BCACP
Shannon Miller comes to UF from Florida Hospital, where she was a family medicine faculty member and an ambulatory care clinical pharmacist for 17 years. Miller received her Pharm.D. degree from the University of Florida College Of Pharmacy and completed a primary care residency at Florida Hospital in Orlando, FL. After residency, she created a faculty position within the family medicine residency and started numerous clinics including anticoagulation, diabetes, hypertension and asthma. Miller worked closely with the family medicine residents and was awarded Faculty of the Year in 2009 and 2010, Lecturer of the Year in 2002, and Outstanding Educator in 2000. While working as an ambulatory care pharmacist with Florida Hospital, she was named University of Florida Preceptor of the Year in 2001, 2003 and 2009.
Miller is a Board Certified Ambulatory Care Specialist. She currently practices in a multi-disciplinary geriatric clinic in Winter Park, Florida. Miller is a recipient of the University of Florida College of Pharmacy Outstanding Teaching Team Award in 2017 and 2018 and the University of Florida College of Pharmacy Teacher of the Year Award in 2018.
Stacy L Miller Pharm.D., M.B.A., BCACP
Stacy Miller received her Doctor of Pharmacy from Butler University in 2007. Upon graduation, she completed a PGY-1 with focus in ambulatory care at Florida Hospital, Celebration Health. Dr. Miller began her academic career as an Assistant Professor at the Sullivan University College of Pharmacy in 2008. During her time at Sullivan, during her time there she earned her Masters of Business Administration, was the Residency Program Director (RPD) for a program she started at Baptist Health Floyd and was also the RPD for a residency program at the Center for Health and Wellness. At Sullivan, she served as the Director of Student Affairs, a role in which she was responsible for creating and implementing the co-curriculum. The focus of Dr. Miller’s clinical practice is on anticoagulation management in the ambulatory care setting. Dr. Miller is a member of the American Pharmacy Association (APhA), American Association of Colleges of Pharmacy (AACP), and the American Society of Health-Systems Pharmacists (ASHP). For ASHP, Dr. Miller is a Residency Program Accreditation Surveyor. Dr. Miller joined the faculty at the University of Florida in 2019 as the Assistant Dean for Clinical Education. In that role, she plays a prominent role in overseeing the quality of experiential programs, developing innovative approaches in experiential education, and leading pre-and post-residency placement activities in the college.
Robin Moorman Li Pharm.D., BCACP, CPE
Robin Moorman Li is currently a Clinical Associate Professor with the University of Florida College of Pharmacy and serves as the Assistant Director of the Jacksonville campus. She received her Bachelor’s degree from Kansas State University in 1996 and completed her Doctor of Pharmacy at University of Kansas in 2000. Moorman Li completed a primary care residency at University of Mississippi Medical Center in 2001, and became a pharmacy practitioner with Shands Jacksonville from 2001 to 2008 where she created a pharmacist driven pain management clinic in a primary care clinic. In 2003, she began teaching part time with the University of Florida College of Pharmacy and transitioned to full time faculty with the College in 2008. Moorman Li practiced at the River Garden Hebrew Home for the Aged from 2008-2016 and is now practicing at UF Health Jacksonville in the Ambulatory Pharmacist ran Pain Management Clinic and also in the Center for Pain Management at UF Health Jacksonville.
Carol A Motycka Pharm.D., BCACP
Dr. Carol Motycka graduated from the University of Florida with her Pharm.D. and completed a residency in Ambulatory Care at Florida Hospital in Orlando. After practicing at Florida Hospital for several years, Motycka joined the University of Florida to help build the College of Pharmacy program in Jacksonville. She is board certified in Ambulatory Care has completed fellowships in both leadership and education. Motycka has been published in multiple academic and clinical journals and has provided over 100 presentations in the field. She has received awards on the state and national level for her teaching, research, and leadership. Motycka is a strong advocate of the profession of pharmacy and serves the profession through public relations events in her community and professional organizations where she has served in multiple capacities including Speaker of the House for the Florida Pharmacy Association and President of Duval County Pharmacy Association. As assistant dean of the University of Florida College of Pharmacy Jacksonville Campus, Motycka spends her time teaching, completing research, advising and administrating.
Jason Powell Pharm.D.
Dr. Powell’s clinical practice is based at the UFHealth Family Medicine Clinic at Eastside, where he supervises WPPD students during their clinical training. Dr. Powell received his Pharm.D. degree from the University of Florida and completed a PGY-1 residency in Ambulatory Care at Eastside under the direction of Drs. Karen Sando and Jim Taylor. During residency training, he also completed the teaching certificate program at the UF College of Pharmacy and was actively involved in the training of IPPE, APPE, and WPPD students.
Teresa E Roane PharmD, MBA, BCACP
Dr. Roane joined the faculty at the University of Florida College of Pharmacy in March 2010 as a Clinical Assistant Professor. She began her career in pharmacy in 1988 working as a pharmacy technician; becoming certified in 2000. She received her Doctor of Pharmacy degree from the University of Florida in 2006. Prior to joining the University of Florida, she worked as a clinical pharmacist at AvMed Health Plans in Gainesville, FL. While at AvMed, she helped develop and lead their medication therapy management program, provided direct oversight of the utilization management program, served as resource for internal and external healthcare professionals as well as a preceptor for UF PharmD students on their APPE rotations. Dr. Roane is currently the Associate Director of the College of Pharmacy’s Center for Quality Medication Management (CQM). The center provides telephonic medication related services to patients on behalf of national healthplans. The center employs UF faculty, student interns, technicians, and pharmacists as well as additional administrative staff. The center also services as an APPE site for UF students and has locations on UF campuses in both Gainesville and Lake Nona. Dr. Roane mentors students and residents located at the center. She also teaches courses within the curriculum that focuses on topics such as MTM, managed care, effective communications, business concepts, and vaccinations/immunizations. She earned her Board Certification as an Ambulatory Care Pharmacist (BCACP) in 2011, and her Master of Business Administration in HealthCare Management degree in 2018. She serves as the Diplomat for the UF Student Chapter of AMCP and is a member of the AMCP Educational Affairs committee.
Kathryn J Smith PharmD, BCACP
Dr. Kathryn Smith received her Doctor of Pharmacy Degree with Leadership Emphasis at the University of Minnesota College of Pharmacy and completed a PGY1 Community and Ambulatory Care Residency with Cub Pharmacy in Minneapolis, Minnesota. Dr. Smith joined the University of Florida College of Pharmacy as a Clinical Assistant Professor in 2014 and maintains a practice site at the University of Florida Physicians Anticoagulation Clinic. Dr. Smith teaches concepts related to ambulatory care practice, Personal and Professional Development, and the Pharmacists’ Patient Care Process throughout the PharmD curriculum. She is the Leadership Professional Certificate Director and teaches leadership concepts in required and elective courses.
Dr. Smith has been a member of AACP since 2011 and currently serves on the AACP Leadership Development SIG Executive and Scholarship committees. In the past, she has served as the Chair of the Council of Faculties Junior Faculty Learning Community.
Dr. Smith’s research interests include personal and professional development, assessing professionalism and other professional attributes, and integrating the Pharmacists’ Patient Care Process into the PharmD curriculum.
Janel Soucie Pharm.D.
Dr. Soucie received her Pharm.D. from Nova Southeastern University College of Pharmacy. She completed a Primary Care Pharmacy Residency at Advent Health Celebration. She has worked as a staff pharmacist in both the inpatient and community pharmacy settings. She initiated and managed an Anticoagulation Management Service at Florida Hospital East Orlando where she received the Model of Excellence award. More recently, she worked as a Clinical Pharmacist Specialist in Anticoagulation at the Orlando VA Medical Center for several years. Dr. Soucie has been Adjunct Clinical Faculty for University of Florida for many years, serving as a preceptor for pharmacy students. She has also been a pharmacy residency preceptor at the Orlando VA Medical Center.
Erin L St. Onge Pharm.D.
Dr. St. Onge joined the faculty in July 2002 to help start the University of Florida College of Pharmacy program in Orlando. As the Associate Campus Director for the Orlando campus, she devotes her time to her various roles as teacher, advisor, and administrator.
Dr. St. Onge graduated from the University of Florida College of Pharmacy with her Doctor of Pharmacy degree with honors in 1999. Upon graduation, she completed a residency in Community Clinical Pharmacy with St. Louis College of Pharmacy/Walgreens. Dr. St. Onge accepted her first faculty position with Texas Tech University School of Pharmacy at their Lubbock campus. During her two years with Texas Tech, she gained valuable experience with their 3-campus (Amarillo, Lubbock, Dallas) distance education program. Also, she developed a community site for 3rd and 4th year students, as well as a residency program in Community Clinical Pharmacy. Dr. St. Onge and her family moved to Orlando in summer of 2002 at which time she accepted the position as Campus Director for Orlando. Dr. St. Onge has practiced ambulatory care in a variety of settings. She currently holds a joint appointment with the University of Central Florida College of Medicine where she provides clinical pharmacy services to patients at UCF Health. Additionally, Dr. St. Onge is very involved with interprofessional education initiatives with several schools/colleges within the University of Central Florida (Medicine, Nursing, Social Work, Physical Therapy, etc). The group was recently awarded the inaugural IPEC/USPHS National Award for Excellence in Interprofessional Education for their efforts at a student/faculty run clinic in Apopka, Florida. In addition to her current position with UF College of Pharmacy, she is very active in national pharmacy organizations and has held numerous leadership positions in state and local pharmacy organizations. Dr. St. Onge’s interests include diabetes mellitus, cardiovascular disease, and women’s health.
James Taylor Pharm.D., CDE, BCACP
Dr. Taylor is a Clinical Associate Professor in the Department of Pharmacotherapy and Translational Research at The University of Florida College of Pharmacy. He received his doctor of pharmacy degree from Ohio Northern University. Upon graduation, he completed an ASHP accredited Pharmacy Practice Residency at The Veterans Affairs Medical Center in Huntington, West Virginia. Subsequently, he completed a Family Medicine Residency at The University of Florida. Dr. Taylor serves as the Director of the Professional Practice Skills Lab series for The UF College of Pharmacy and also coordinates the third year lab courses. He also is responsible for oversight of the third and fourth year OSCEs. Dr. Taylor currently serves as the Pharmacy Director for the UF and Shands Anticoagulation Clinic. In past years he practiced in a family practice clinic and served as residency director for an Ambulatory Care Residency. Dr. Taylor has had an active role in the Laboratory Instructors SIG since 2016, serving as chair of the mentoring and networking committee for the past three years. He has presented at the AACP Annual Meeting on Lab SIG topics as well as lead Lab SIG webinars. He has given numerous other professional presentations on diabetes, anticoagulation and other primary care topics. He has also published extensively on primary care topics and educational topics such as OSCEs. Finally, he has served as Principal Investigator and Co-Principal Investigator for a number of clinical trials. Current research interests include assessing APPE readiness and anticoagulation. Finally, he is a certified diabetes educator and board certified ambulatory care pharmacist.
Katherine Vogel Anderson Pharm.D., BCACP
After completing a primary care pharmacy residency, Dr. Vogel Anderson worked as a clinical pharmacy specialist at the Malcom Randall Veterans Affairs Medical Center, where she specialized in anticoagulation management. She held this position for five years, before transferring to the VA geriatric primary care clinic, where she managed anticoagulation, hypertension, diabetes, and other chronic conditions, as part of a multi-disciplinary health care team. Since 2005, Dr. Vogel Anderson has precepted UF pharmacy students on their ambulatory care rotation. In 2010, she joined the faculty full time in the Department of Pharmacotherapy and Translational Research; she has a joint appointment in the UF College of Medicine. Currently, Dr. Vogel Anderson practices at UF Health Internal Medicine at the Medical Plaza. Her research interests include anticoagulation therapy, pharmacist/physician collaboration, and improving medication management at each patient care transition. In 2012, she established the first ASHP accredited PGY1 pharmacy residency program at the UF COP, for which she serves as program director. Dr. Vogel Anderson is faculty advisor for the UF student ACCP chapter, is co-advisor for KE, and served as chair of the UF Faculty Senate in 2018-2019. In 2009, Dr. Vogel Anderson and her husband, Shawn Anderson, established the endowed Vogel/Anderson Exceptional Leader Scholarship for third year pharmacy students. In her free time, Dr. Vogel Anderson likes to attend Gators events and go RV’ing with Shawn and their dogs, Teddie Roosevelt and Johnnie Adams.
Karen Whalen Pharm.D., BCPS, FAPhA
Dr. Whalen received her Doctor of Pharmacy degree with highest honors from the University of Florida. She completed a Pharmacy Practice Residency at the Moses Cone Health System followed by a Primary Care Residency at the James A. Haley Veterans’ Hospital. Following residency training, Dr. Whalen was a faculty member in the Department of Pharmacy Practice at Nova Southeastern University (NSU) for 12 years. While at NSU College of Pharmacy, she was an eight-time recipient of the Golden Apple Award for Teaching Excellence. In 2008, Dr. Whalen joined the faculty of the University of Florida College of Pharmacy as assistant director of the St. Petersburg Campus. In 2010, she transitioned to the main campus in Gainesville. She now serves as the Assistant Dean for Curricular Affairs and a Clinical Professor in the Department of Pharmacotherapy and Translational Research. Her excellence in teaching has been recognized with the Faculty Recognition Award in 2011 and 2012, and the Teacher of the Year Award in 2013.
Dr. Whalen is a Board Certified Pharmacotherapy Specialist. She has practiced ambulatory care pharmacy in a variety of settings including an academic family medicine center, community pharmacy practice, and a Veterans’ Affairs Healthcare System. Dr. Whalen is active in local, state and national pharmacy organizations, and is a Fellow of the American Pharmacists Association and a past president of the Florida Pharmacy Association. She is a past recipient of the National Community Pharmacists Association Pharmacy Leadership Award, and the Florida Pharmacy Association Jean Lamberti Mentorship Award.
Kristin Wiisanen Pharm.D., FAPhA, FCCP
Kristin Wiisanen Weitzel received her PharmD from the University of Florida in 1998 and completed residency training at the Medical College of Virginia. Dr. Wiisanen Weitzel is currently Associate Director of the University of Florida Health (UF Health) Personalized Medicine Program, Director of Continuing Pharmacy Education, and Clinical Professor in the Department of Pharmacotherapy and Translational Research in the College of Pharmacy. Dr. Wiisanen Weitzel leads educational efforts in the UF Health Personalized Medicine Program, serves as chair of the Provider Adoption Barriers and Education working group for the NIH-funded IGNITE Genomic Medicine Network, previous past chair of the Pharmacogenomics Special Interest Group for the American Association of Colleges of Pharmacy, and Residency Program Director for an accredited postgraduate Pharmacogenetics Residency program. She is Editor-in-Chief of Pharmacy Today for the American Pharmacists Association (APhA), a fellow of APhA, and a University of Florida Entrepreneurial Faculty Fellow.
Division of Health-System Based Pharmacotherapy
Kalen B Manasco Pharm.D., BCPS, FCCP, FPPAG
Kalen Manasco received a B.S. degree in microbiology and a Pharm.D. degree from the University of Georgia. After graduation, she completed a pharmacy practice residency at Shands Hospital at the University of Florida in Gainesville, Florida, and a pediatric specialty residency at the Medical University of South Carolina in Charleston, South Carolina. She served as a clinical associate professor at the University of Georgia College of Pharmacy from 2007-2017, where she also served as the PGY2 pediatric pharmacy residency program director. From 2003-2007, she served as a clinical assistant professor in the department of clinical and administrative sciences at Mercer University College of Pharmacy and Health Sciences in Atlanta, Georgia. Manasco joined the University of Florida College of Pharmacy in March 2017, as a clinical professor in the department of pharmacotherapy and translational research. She is also a clinical pharmacist with UF Health Shands Children’s Hospital in the pediatric intensive care unit. Her research interests include pediatric infectious disease and pediatric pulmonology (cystic fibrosis and asthma). Manasco is a board certified pharmacotherapy specialist, chair of the ACCP Pediatric Practice and Research Network, and co-series editor for the pediatric pharmacotherapy self-assessment program.
John M Allen Pharm.D., BCPS, BCCCP, FCCM
John M. Allen, Pharm.D., BCPS, BCCCP, FCCM is a clinical assistant professor at the University of Florida College of Pharmacy Orlando Campus. Born and raised in Philadelphia, Dr. Allen joined the College in 2018. Dr. Allen’s professional areas of interest include antimicrobial stewardship in the intensive care unit (ICU), sedation and analgesia in the critically ill, nutrition in the critically ill and strategies used to mitigate drug shortages in the ICU setting.
Dr. Allen graduated with his Doctor of Pharmacy degree from Florida A&M University in Tallahassee, FL. He then completed a PGY-1 residency, followed by a PGY-2 Critical Care residency at Tampa General Hospital, in Tampa, FL. Dr. Allen is a dual board-certified pharmacist in critical care, and pharmacotherapy.
Dr. Allen is an active member of the Society of Critical Care Medicine, American College of Clinical Pharmacy and the Florida Society of Health-System Pharmacists and has been appointed to committees within the three organizations. In 2017, Dr. Allen received the prestigious honor of induction as a Fellow of the American College of Critical Care Medicine, which honors individuals whose achievements and contributions demonstrate personal commitment to critical care excellence, a distinction at the time of his induction bestowed upon seven pharmacists in the state of Florida.
Prior to his appointment at the University of Florida, Dr. Allen has held a variety of diverse administrative experiences including serving as a pharmacy clinical coordinator, pharmacy residency program director, and director of infectious diseases pharmacy for a 16-hospital system. In his free time, Dr. Allen enjoys watching anything with four wheels going fast, traveling and spending time with his wife and three children.
Shauna Buring Pharm.D.
Shauna Buring, Pharm.D., assumed the leadership role as associate dean for student affairs in May 2016, and in July 2018, she moved into her current position as Associate Dean for Professional Education.
Buring joined UF following 14 years at the University of Cincinnati James L. Winkle College of Pharmacy, her alma mater. She most recently served as associate dean for professional education and assessment where she helped UC secure an eight-year accreditation from the Accreditation Council for Pharmacy Education. In addition, she has led many curricular improvements, including the development of new pharmacy practice skills lab courses and a teaching certificate program for first-year pharmacy residents in the Cincinnati area. Prior to her work at UC, Buring was an assistant professor at Auburn University Harrison School of Pharmacy.
With the appointment, Buring returned to Florida where she started her professional pharmacy career as a staff pharmacist at Lee Memorial Hospital in Fort Myers from 1991-94. Additionally, she completed a drug information specialty residency at Shands Hospital in Gainesville in 1997.
Christopher T Campbell Pharm.D., BCPPS
Christopher Campbell, Pharm.D., received his Doctor of Pharmacy degree from Northeastern University. Following graduation, he completed a PGY1 Pharmacy Residency and a PGY2 Pediatric Pharmacy Residency at Georgia Regents Medical Center in conjunction with the University of Georgia College of Pharmacy. He joined the faculty at the University of Florida in August 2016 and maintains a clinical practice site at UF Health Shands Hospital in the Pediatric Intensive Care Unit (PICU) and Pediatric Cardiac Intensive Care Unit (PCICU). He has spoken and presented at state and national meetings and currently serves as the Vice-Chair of the Vizient Pediatric Pharmacy Committee. His interests include pediatric critical care, anticoagulation, and patient safety.
Anthony M Casapao Pharm.D., M.P.H.
Anthony M. Casapao received his Doctor of Pharmacy degree from Wingate University in Wingate, North Carolina. He then pursued post-graduate training at St. Vincent’s Medical Center in Jacksonville, Florida, by completing an American Society of Health-System Pharmacists, or ASHP, -accredited pharmacy practice residency. Casapao continued his post-graduate training at University of Pittsburgh Medical Center in Pennsylvania, completing an ASHP-accredited specialty practice residency in infectious diseases. Upon completion of his residency, he maintained his interest in infectious diseases and pursued an American College of Clinical Pharmacy peer reviewed pharmacotherapy fellowship in infectious diseases and health outcomes. After achieving five years post-graduate training, Casapao served as an assistant professor in the department of pharmacy practice at Husson University School of Pharmacy in Bangor, Maine. Casapao joined the University of Florida in October 2017, as a clinical assistant professor in the department of pharmacotherapy and translational research.
Lindsey Childs-Kean Pharm.D., M.P.H., BCPS
After completing her Pharm.D. from the University of Florida College of Pharmacy, Dr. Childs-Kean completed a PGY-1 residency at Tampa General Hospital in Tampa, FL, followed by a PGY-2 residency in Infectious Diseases Pharmacy at the South Texas Veterans Affairs Healthcare System in San Antonio, TX. Prior to joining UF full-time, she was the Hepatology Pharmacy Program Manager at Bay Pines VA Healthcare System in Bay Pines, FL. In that role, she established a pharmacist-led Hepatitis C clinic for patients throughout the Bay Pines System, including patients seen using Clinical Video Telehealth technology. Her professional interests include infectious diseases pharmacotherapy as well as professional development of students and new practitioners. Dr. Childs-Kean is active in many professional organizations at the state and national level, including the American Society of Health-System Pharmacists and the Florida Society of Health-System Pharmacists.
Randell E Doty Pharm.D.
Dr. Doty received a Doctor of Pharmacy degree from the University of Tennessee in 1988 and completed a general clinical residency at the Veterans Administration Medical Center in Memphis Tennessee in 1989. He accepted an appointment in the Department of Pharmacy Practice at the University of Florida in 1989 and served as Associate Director of the Computer Applications in Pharmacy Center until it closed in 1991. Dr. Doty is a Clinical Associate Professor in the Department of Pharmacotherapy and Translational Research. He served for more than 20 years as director of Experiential Programs at the University of Florida College of Pharmacy and currently co-coordinates the Pathophysiology and Patient Assessment course sequence in the first year. He also teaches in the skills lab, instructs students in their immunization training and practices in the UF Health adult Emergency Department.
Carinda J Feild Pharm.D.
Dr. Feild earned her Pharm.D. degree from the University of Florida in 1989. She then completed an ASHP accredited two-year residency with emphasis in critical care at the University of Kentucky and a two-year critical care fellowship at the University of Kentucky’s Drug Product Evaluation Unit. She joined UF College of Pharmacy faculty in 2010 as a Clinical Associate Professor and previously served as assistant campus director for the St Pete Campus.
Prior to taking this position, she worked at the R Adams Cowley Shock Trauma Center / University of Maryland Medical Center for seven years. For the last four of those years she served as the critical care research section manager and a clinical research pharmacist. For the 10 years prior she worked as a clinical pharmacy specialist in critical care caring for surgical, cardiothoracic, and trauma patients and teaching pharmacy students at Boston University Medical Center, Orlando Regional Healthcare System where she also served as the Clinical Coordinator, and Keesler Air Force Base Medical Center where she was also involved in research. She has been an Assistant Professor with the University of Florida’s Working Professional Pharm.D Program since 1997. She started as an Orlando site facilitator and has also served as the regional director, a course coordinator and advisor, a pharmaceutical care project reviewer, and currently works on special projects. She was awarded the Air Force Clinical Research Award for work done at Keesler in 2001 and she was the Spring 2007 recipient of the Faculty Service Award for the WPPD program.
Adonice Khoury Pharm.D., BCPS
Adonice Khoury is a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research and Clinical Specialist in Internal Medicine at UF Health/Shands Hospital. Dr. Khoury received a B.S. in Microbiology & Cell Science from the UF College of Agriculture and a Doctor of Pharmacy degree from the UF College of Pharmacy. He also completed an ASHP accredited specialty residency in Geriatric pharmacy practice at the Malcom Randall VA Medical Center in Gainesville. Prior to joining the college, Dr. Khoury was the head clinical pharmacist and antimicrobial stewardship pharmacist for six years at Select Specialty Hospital in Gainesville, a 44-bed long-term acute care hospital. Dr. Khoury was active with the college at Select Specialty Hospital, serving as a preceptor for adult medicine APPE rotations. His primary clinical practice and research interest is in internal medicine with specific interests in the subspecialties of gastrointestinal and infectious diseases pharmacotherapy.
Priti Patel Pharm.D.
Dr. Patel completed and ASHP-accredited drug information residency at the Thomas Jefferson University Hospital in Philadelphia and McNeil Consumer and Specialty Pharmaceuticals in Fort Washington, PA. Prior to joining UF, she was an associate clinical professor at St. John’s University College of Pharmacy and Allied Health Professions, and co-director of the St. John’s University drug information service at Long Island Jewish Medical Center.
Barbara Santevecchi Pharm.D., BCPS, BCIDP
Barbara Santevecchi joined the College of Pharmacy as a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research in August 2019. She serves as an Infectious Diseases Clinical Specialist and member of the Antimicrobial Management Program at UF Health Shands Hospital. She received her Doctor of Pharmacy degree from Wingate University School of Pharmacy in Wingate, North Carolina in 2015. Following graduation, she completed PGY1 Pharmacy Practice and PGY2 Infectious Diseases pharmacy residencies at the Medical University of South Carolina in Charleston, South Carolina. After completing residency training, she worked as an Infectious Diseases Clinical Pharmacist at Atrium Health in Charlotte, North Carolina. Barbara holds dual board certification in pharmacotherapy and infectious diseases. Her research interests include HIV/AIDS, microbiology, rapid diagnostics, novel agents for multidrug resistant infections, and antimicrobial stewardship. Barbara has published research in several peer-reviewed journals and has delivered presentations on her research at national meetings.
Bethany Shoulders Pharm.D., BCCCP
Bethany Shoulders, Pharm.D., joined the College of Pharmacy as a clinical assistant professor in the department of pharmacotherapy and translational research in July 2016. She maintains a clinical practice site at the trauma ICU at UF Health Shands Hospital.
Shoulders received her Pharm.D. degree from the University of Tennessee Health Science Center in 2014. She then completed a pharmacy practice residency at The Johns Hopkins Hospital in Baltimore and travelled to Pittsburgh to complete her PGY2 critical care pharmacy practice residency with the University of Pittsburgh Medical Center. Her research endeavors during residency included evaluating intraoperative continuous infusion cefazolin in a cardiac surgery population and characterizing the guideline evidence behind off-label medication use in the intensive care unit.
Lisa Vandervoort Pharm.D.
Lisa Vandervoort received her Doctor of Pharmacy degree from the University of Florida College of Pharmacy in 1995 and completed a Pharmacy Practice Residency at Shands Hospital at the University of Florida in 1996. She spent 10 years as the Clinical Specialist in Infectious Disease/Internal Medicine at Orlando Regional Medical Center. For the past 10 years Dr. Vandervoort has been at the University of Florida both at the Orlando Campus and with the WPPD program. Her primary interests include student development, pharmacokinetics, infectious disease and internal medicine.
Veena Venugopalan Pharm.D.
Veena Venugopalan received her Doctor of Pharmacy degree from the University of Kentucky College of Pharmacy. Following graduation, she completed her pharmacy practice residency and infectious diseases specialty residency at the University of Kentucky Medical Center. As a board certified pharmacist with added qualifications in infectious diseases pharmacotherapy, Venugopalan has developed and maintained antimicrobial stewardship programs at large academic centers as well as community teaching hospitals. She joined the faculty at the University of Florida College of Pharmacy as an assistant professor in January 2016. She serves as the infectious diseases clinical specialist at UF Health Shands Hospital. Her research and patient care activities focus on health care associated infections, multidrug resistant gram-negative infections and antimicrobial stewardship. Her work has been published in peer-reviewed journals, and she has been presented at national and international conferences.
Stacy A Voils Pharm.D., M.S., BCPS, FCCM, FCCP
After his graduation from the University of Kentucky College of Pharmacy, Dr. Voils worked briefly as a clinical pharmacist. He then completed a PGY-1 Pharmacy Practice residency at the VA Medical Center in Lexington, Kentucky followed by a PGY-2 residency specializing in critical care at the Virginia Commonwealth University Health System (VCUHS) in Richmond, Virginia. Before joining the University of Florida, Dr. Voils worked as a Clinical Pharmacy Specialist in Neurosurgery and Cardiothoracic Surgery at the VCUHS, Medical College of Virginia campus. He held an appointment as Clinical Assistant Professor at the Virginia Commonwealth University School of Pharmacy.
Division of Translational Research
Larisa H Cavallari Pharm.D., BCPS, FCCP
Dr. Cavallari received her B.S. Pharmacy and Pharm.D. degrees from the University of Georgia. She then completed a Pharmacy Practice Residency at the Veterans Affairs Medical Center in Memphis, Tennessee and a fellowship in Cardiovascular Pharmacogenomics at the University of Florida. Dr. Cavallari accepted a position as an Assistant Professor of Pharmacy Practice at the University of Illinois at Chicago after completing her training and was promoted to Associate Professor in 2009. While at UIC, she directed efforts to implement genotype-guided warfarin dosing for all patients newly starting warfarin during hospitalization. Dr. Cavallari joined the University of Florida Department of Pharmacotherapy and Translational Research as an Associate Professor in April, 2014, where she serves as director of the Center for Pharmacogenomics and Precision Medicine. She also serves as Director of the UF Health Precision Medicine Program. Her research involves discovery and clinical translation of genetic variants related to drug response and has been funded by the NIH, FDA, American Heart Association, and other awards.
Dr. Cavallari has served on both NIH and American Heart Association grant review committees and is a Board Certified Pharmacotherapy Specialist, Fellow of the American College of Clinical Pharmacy, former Chair of the American College of Clinical Pharmacy Research Institute, and Editorial Board Member for the Lexi-Comp pharmacogenetics series.
Jürgen Bulitta Ph.D.
Jürgen B. Bulitta, PhD, is an Associate Professor in the Department of Pharmacotherapy and Translational Research at the UF College of Pharmacy. He is supported by the University of Florida’s pre-eminence program in Drug Discovery and Development, and received the Perry E. Foote Eminent Scholar Chair, Endowed Professorship, in 2019. Dr. Bulitta’s research focuses on combating multidrug-resistant bacterial ‘superbugs’ which present one of the three most serious threats to human health.
His mission is to optimize patient therapies and innovative drug development by providing a focal point for translational research in infectious diseases and related areas, and to serve as an internationally-leading, interdisciplinary, collaborative program for translational research.
Dr. Bulitta’s vision is to provide novel solutions and great hope for patients with serious, life-threatening infections by developing new safe and effective therapies. These are informed at the molecular level by an innovative combination of mechanistic, in vitro, animal and quantitative approaches to rationally optimize outcomes in patients. His highly collaborative research program leverages latest pharmacological, microbiological, biochemical and computational approaches. This creates unique translational insights that enable novel therapies and dosing strategies, as well as the design and development of new drugs. We work hard so that we can say “we have an effective therapy for you” when you most need it.
He won 26 peer-reviewed grants (15 as PI) from the NIH, FDA, the Australian equivalents of NIH and NSF, as well as 30 collaborative projects with pharmaceutical industry (total: $35M, 18M active). Dr. Bulitta published 140 peer-reviewed papers and contributed to over 97 phase I-IV clinical trials. He reviewed for several NIH study sections and received 23 awards since 1998. These include the Giorgio Segré Prize 2010 for distinct contributions in the field of pharmacokinetics and pharmacodynamics by the European Federation for Pharmaceutical Sciences (EUFEPS) and the 2012 ASCEPT Denis Wade Johnson & Johnson New Investigators Award. Dr. Bulitta created the Translational Clinical Pharmacology course (PHA6133). He is the creator and developed of the SADAPT-TRAN package that greatly facilitates the development of systems pharmacology models in the S-ADAPT population modeling package.
Rhonda M Cooper-Dehoff Pharm.D., M.S., FAHA, FACC, FCCP
Dr. Cooper-DeHoff is a Associate Professor in the Department of Pharmacotherapy and Translational Research, and the Department of Pharmaceutics in the College of Pharmacy, and in the Division of Cardiovascular Medicine, College of Medicine at the University of Florida.
David DeRemer Pharm.D., BCOP, FCCP, FHOPA
David DeRemer received his B.S. Biology and Pharm.D. degrees from the University of Kentucky. Following graduation, he completed a Pharmacy Practice Residency and an Oncology specialty residency at the University of Kentucky Chandler Medical Center. He followed that with an Oncology Postdoctoral Fellowship focusing on Drug Discovery/Development at the University of Kentucky. DeRemer is a fellow of the American College of Clinical Pharmacy (ACCP) and the Hematology Oncology Pharmacist Association (HOPA). He is currently the President-Elect for HOPA and actively participates in multiple HOPA committees. He joined the University of Florida College of Pharmacy in September 2017 and is actively participating in early phase UF Health Cancer Center clinical trials.
Julio Duarte Pharm.D., Ph.D.
Julio Duarte received his Pharm.D. and Ph.D. degrees from the University of Florida. After completing training, he became an assistant professor of pharmacy practice at the University of Illinois at Chicago where he served for over four years. While there, Dr. Duarte became the director of the pharmacogenomics laboratory, and also co-director of the University of Illinois Hospital Personalized Medicine Program. In late 2015, he returned to the University of Florida as an assistant professor within the department of pharmacotherapy and translational research. Dr. Duarte’s research interests include the biological mechanisms behind both disease development and drug response in heart failure and pulmonary hypertension. His NIH-funded laboratory conducts translational research, attempting to discover genomic predictors of drug response, as well as using genomics to identify novel targets for future drug development. He has served on U.S Department of Defense grant review committees and is also an active member of the Council for Functional Genomics and Translational Biology within the American Heart Association.
Reginald Frye Pharm.D., Ph.D., FCCP
Dr. Frye is a Professor and Chair for the Department of Pharmacotherapy and Translational Research College of Pharmacy. He received a B.S. in Biology from Oglethorpe University, a Pharm.D. from Mercer University School of Pharmacy, and a Ph.D. in Clinical Pharmaceutical Sciences from the University of Pittsburgh School of Pharmacy. After completing graduate work, Dr. Frye remained on faculty at the University of Pittsburgh from 1995 until 2003, being promoted to Associate Professor with tenure in 2002. He joined the faculty at the University of Florida in July 2003 and in July 2012, he was promoted to Professor.
Yan Gong Ph.D.
Yan Gong, Ph.D., is an Associate Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida (UF) College of Pharmacy and the UF Center for Pharmacogenomics and Precision Medicine. Dr. Gong received a Ph.D. in Pharmaceutics in 2004 from Department of Pharmaceutics, College of Pharmacy at UF. She also obtained a Master’s Degree in Statistics in 2003 from UF Department of Statistics. Before joining the UF faculty in 2005, she completed one year of post-doctoral fellowship in Cardiovascular Pharmacogenomics at the UF Center for Pharmacogenomics.
Dr. Gong’s research focuses on pharmacogenomics of efficacy and adverse response of antihypertensives medications, and serious adverse drug events such as medication-related osteonecrosis of the jaw (ONJ) and cardiotoxicities related to cancer therapies (Cardio-Oncology). Dr. Gong is a NIH-funded investigator for multiple R01s and U01s. Dr. Gong was also funded by the Clinical and Translational Science Institute (CTSI) to 1). develop a computable phenotype for cancer drug induced cardiotoxicity in the Electronic Health Records in order to evaluate this clinically significant adverse event in the real-world settings of OneFlorida Clinical Research Consortium; 2). To identify pharmacogenomic, medical imaging biomarkers and clinical factors associated with cardiotoxicity related to cancer therapies through a multimodal approach using existing data from the UK Biobank. Dr. Gong is also leading the newly established Cardio-Oncology Research Interest Group in the Cardiovascular Collaborative Research Group of the National Patient-centered Clinical Research Network (PCORnet). Dr. Gong has authored over 140 peer-reviewed publications.
In addition to research, Dr. Gong has been involved in teaching multiple graduate level and professional level courses at the UF College of Pharmacy and College of Medicine. She is currently the course coordinator for Pharmacogenomics (PHA6449), a required graduate level course for the Department of Pharmacotherapy and Translational Research at the UF College of Pharmacy.
Julie A Johnson Pharm.D.
Julie A. Johnson, Pharm.D., is dean of the University of Florida College of Pharmacy and distinguished professor of Pharmacy and Medicine. She received her B.S. in Pharmacy from the Ohio State University and her Pharm.D. from the University of Texas at Austin and the UT Health Science Center at San Antonio. She completed a post-doctoral fellowship in cardiovascular pharmacology/pharmacokinetics at Ohio State.
Johnson’s research focuses on cardiovascular pharmacogenomics and genomic medicine implementation. She is an internationally-recognized leader in pharmacogenomics and genomic medicine, with over 290 peer reviewed publications and nearly $50 million in research funding as principal investigator. In 2015, 2016, 2017 she was named a Thomson Reuters (now Clarivate Analytics) Highly Cited Scientist in Pharmacology and Toxicology, and in 2018 in the Cross Discipline category, indicating she is in the top 1% of the most highly cited scientists in the field globally.
Johnson has served on the Nonprescription Drugs Advisory Committee of the FDA, the XNDA Study Section at NIH, and in numerous scientific capacities with NIH’s NHLBI. She has had leadership roles in the American College of Clinical Pharmacy (ACCP), the American Heart Association (AHA), and the American Society of Clinical Pharmacology and Therapeutics (ASCPT), for which she completed her term as President in 2017. She is an elected fellow of the ACCP, the AHA and the American College of Clinical Pharmacology (ACCP-Pharmacology). Johnson was elected to the National Academy of Medicine (formerly Institute of Medicine) in 2014 and has received numerous other awards including teaching awards from both the University of Tennessee (1996) and the University of Florida (2001); the Ohio State University Alumni Association William Oxley Thompson Award for early career achievement (1997), Leon I Goldberg Young Investigator Award from the ASCPT (2004), Paul Dawson Biotechnology Research Award, American Association of Colleges of Pharmacy (AACP) (2007), Therapeutic Frontiers Award (2009) and Russell R Miller Award for Contributions to the Literature (2010), both from ACCP, the Southeastern Universities Research Association Distinguished Scientist Award (2015); AACP Volwiler Research Achievement Award (2016), the ACCP-Pharmacology Distinguished Scientist Award (2019), and ACCP Paul Parker Medal (2019), among others.
Jatinder Lamba Ph.D., M.Sc.
Dr. Jatinder Lamba is currently Professor in the Department of Pharmacotherapy and Translational Research. She did her post-doctoral training at St. Jude Children’s Research Hospital in Memphis, Tennessee. Prior to joining University of Florida, she was an Associate Professor at University of Minnesota, Department of Experimental and Clinical Pharmacology, College of Pharmacy and the Director of the Pathway driven Pharmacogenomics; University of Minnesota Alliance (PUMA) Institute of Personalized Medicine.
Dr Lamba’s research is focused on identification, characterization and clinical validation of genomic/epigenomic markers predictive of therapeutic outcome in cancer patients. This research spans from preclinical basic research comprising the discovery phase utilizing cell line model systems to translational/clinical phase in patient populations from multi-institute clinical trials. The long-term goal of her research is to move pharmacogenetic testing into the clinical setting to improve safety and efficacy of drug therapy. Dr. Lamba’s research on pharmacogenomics of anti-leukemic agents has been funded by NIH/NCI since 2008. Specifically, her current NCI funded R01 focuses on pharmacogenomics/ epigenomics of cytarabine (ara-C), a nucleoside analog that is the backbone of anti-leukemia chemotherapy in pediatric AML patients. Her group is working on developing algorithms to incorporate pharmacogenomics/epigenomic markers with other prognostic factors to advance precision medicine in oncology. Identification of such patients upfront will provide opportunity to tailor the initial chemotherapy to achieve maximum benefit.
Dr. Lamba’s lab is the first one to identify genetic polymorphisms in CD33 gene that are predictive of response to CD33 targeted agents in AML. These results hold promise in utilizing preemptive genotype to select patients most likely to benefit from CD33-directed therapy such as gemtuzumab ozogamicin in treating AML. Previous work on CD33 genomics was funded by NCI and more in-depth characterization of CD33 as AML therapeutic target is funded by a recent award from leukemia Lymphoma Society.
Given a critical gap of our understanding in metabolic dysregulation in AML, Dr. Lamba’s group is focused understanding the metabolomics differences and biomarkers of prognostic significance in pediatric AML. Dr. Lamba’s recent work is focused towards utilizing transcriptomics to build and refine leukemic stem cell signatures and AML drug response signatures of prognostic and predictive value in AML.
Dr. Lamba has served as chair of Pharmacogenomics SIG at AACP (2013) and is currently vice-chair of Pharmacogenomics focus group with AAPS. She has served as a grant reviewer for numerous NIH study sections and has reviewed grants for international agencies as Italian Ministry of Health. She has published more than 90 research articles in peer-reviewed journals and is on the editorial boards of Leukemia and Lymphoma, Pharmacogenomics and Frontiers in Pharmacogenomics and genomics, JCMM. Dr. Lamba is currently Professor in College of Pharmacy and is also Graduate Program coordinator for PTR department. Dr. Lamba is very committed towards training of future generation of scientist. She has trained 6 Ph. D students, 5 Post-doctoral fellows several Pharm D students and 3 hematology-oncology fellows and several under-graduate students including minority and underrepresented students.
Taimour Langaee MSPH, Ph.D.
Dr. Langaee is a Research Associate Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida (UF) College of Pharmacy and Director of the UF Center for Pharmacogenomics Genotyping Core Laboratory. Before joining the UF faculty in 2002, he completed three years of post-doctoral fellowship in Immunology and Molecular Biology, and Microbiology and Molecular Genetics working on developing HIV vaccine at the College of Medicine University of Montreal and High Density DNA chips for Pseudomonas aeruginosa at the College of Medicine University of Florida.
Dr. Langaee’s research interests are focused on pharmacogenetics (genetic-based variability in drug response) in cardiovascular and auto-immune diseases and developing microarray-based technology methods to facilitate disease diagnosis, genotyping of patients and discovering disease-gene associations.
John S Markowitz Pharm.D., BCPP
Dr. Markowitz received his BS in Biology from Memphis State University, and his Doctorate in Pharmacy (Pharm.D.) from the University of Tennessee Center for the Health Sciences (UTCHS). He completed an ASHP-accredited specialty residency in Psychiatric Pharmacy Practice, also at UTCHS. Following his education and training, Dr. Markowitz served for a decade as a Clinical Specialist in Psychiatry, and eventually Clinical Coordinator within the Institute of Psychiatry at the Medical University of South Carolina (MUSC) in Charleston, South Carolina. He eventually transitioned from clinician to a primary faculty research position in the MUSC College of Pharmacy’s Department of Pharmaceutical & Biomedical Sciences with a dual appointment in the Department of Psychiatry and Behavioral Sciences where he had remained prior to joining the UF College of Pharmacy in 2009. Dr. Markowitz has been credentialed by the Board of Pharmaceutical Specialties in Psychiatric Pharmacy (BCPP) since 1997 and is a founding member of the College of Psychiatric and Neurologic Pharmacists (CPNP).
Caitrin W McDonough Ph.D.
Dr. McDonough received a B.S. in Biochemistry (with a minor in chemistry) from the University of Iowa and then earned a Ph.D in Molecular Medicine and Translational Science from Wake Forest University School of Medicine. Dr. McDonough’s dissertation work focused on the Genetics of Type 2 Diabetic End-Stage Renal Disease in African Americans. After completing graduate studies, she joined the Department of Pharmacotherapy and Translational Research as a Post-Doctoral Associate in Cardiovascular Pharmacogenomics under the direction of Dr. Julie Johnson.
Dr. McDonough is an investigator in the Center for Pharmacogenomics and plays a central role in the development of genetics education programming for the UF&Shands Personalized Medicine Program. She also teaches Genetic Medicine concepts to pharmacy students in the Personalized Medicine course.
Khoa A Nguyen Pharm.D.
Khoa Nguyen, Pharm.D., received his Doctor of Pharmacy degree from the University of Michigan, College of Pharmacy. He then completed a fellowship in medical informatics at the VA Indianapolis, HSR&D. After his fellowship, he joined the Regenstrief Institute, Center for Health Services Research as a research scientist and Purdue University, College of Pharmacy as a Visiting Assistant Professor. Currently, Khoa is a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida, College of Pharmacy. His clinical practice is within the UF Health Personalized Medicine Program to help develop and improve pharmacogenomic clinical decision supports. Dr. Khoa Nguyen’s research interests include human-computer interaction, pharmacogenomics, and health informatics. His research focused on improving patient safety through medication use from two approaches: qualitative research and quantitative research. Using the qualitative research approach, Dr. Nguyen wants to utilize human factor engineering and human-computer interaction method to develop and implement pharmacogenomic clinical decision supports (PGx-CDS). PGx-CDS, when implemented, can foster pharmacogenomics service to predict and prevent severe adverse drug reactions from genetic mutations. Using the quantitative research approach, he wants to identify risk factors that can increase the risk of adverse drug reactions from literature and healthcare organizations’ data. Dr. Nguyen also wants to identify subpopulations that can have genetic testing cost-effectively.
Folakemi Odedina Ph.D.
Folakemi Odedina works on the development of a predictive behavioral model of prostate cancer disparities among Black men and the implementation of cost-effective, community-based intervention programs in minority and underserved communities.
Odedina’s research program focuses on the predictors of health disparities and cost-effective, community-based behavioral interventions to improve the health of Black men. She has directed more than 20 research projects, including: (1) the Florida A&M University Center for Minority Prostate Cancer Training and Research (CMPC), which comprises a trans-disciplinary team of clinical, behavioral and basic scientists; and (2) a landmark Department of Defense prostate cancer research project which accrued over 3,000 Black men in Florida. Her initiatives include the Men’s Health Initiative and the Black Men’s Health Consortium in Florida.
Odedina’s research traverses across the world with an international consortium group in Africa, Caribbean Islands, Europe and the United States. She has received numerous awards for her work, including the 1st American Society of Health-Systems Pharmacy/ Association of Black Health-System Pharmacists Leadership Award for Health Disparities (2009); American Association for Cancer Research – MSI Faculty Award in Cancer Research (2007, 2002, 1998); US Fulbright Scholar award (2006 – 2007); Role Model Award Citation by Minority Access Inc (2005); and Association of Black Health-system Pharmacists Research and Publication Achievement Award (2004). She is also noted in Who’s Who in America and Who’s Who in Science and Engineering publications. Odedina currently serves on several international, national and state initiatives for cancer.
Charles Peloquin Pharm.D.
Prior to coming to the University of Florida, Dr. Peloquin completed a hospital pharmacy residency at Duke University Medical Center, where he also served on the clinical staff. He also completed a fellowship in Infectious Diseases and Pharmacokinetics at the Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital, Buffalo, N.Y. For 20 years, Dr. Peloquin was the Director of the Infectious Disease Pharmacokinetics Laboratory (IDPL) at National Jewish Medical and Research Center, Denver, CO. He now serves as Professor of Pharmacy and Medicine at UF, where the IDPL is now located. Dr. Peloquin and his lab are part of the UF Emerging Pathogens Institute. He also is a consultant to the FDA and CDC.
Nathan D Seligson Pharm.D.
Dr. Seligson earned his Doctor of Pharmacy degree from the University of South Florida in 2015 prior to completing a pharmacy practice residency in 2016. Dr. Seligson then completed a post-doctoral fellowship in translational hematology/oncology focused on precision medicine in sarcoma.
Dr. Seligson is now a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research. His clinical practice includes activities as a clinical pharmacogenomics specialist and hematology/oncology research scientist at Nemours Children’s Specialty Care in Jacksonville, Florida.
Dr. Seligson has been published in as first author in leading journals including: JAMA Open Network, The Oncologist, and Oncotarget. His current research includes work to better understand cancer biology and tumor evolution in order to provide actionable molecular subtyping and pharmacogenomic therapy guidance in sarcoma.
Steven M Smith Pharm.D., M.P.H.
Steven Smith is an Assistant Professor in the Department of Pharmacotherapy and Translational Research and serves as Associate Director for the UF Center for Integrative Cardiovascular and Metabolic Diseases.
He received his PharmD degree from the University of Florida College of Pharmacy. He then completed a PGY-1 residency at the North Florida/South Georgia Veterans Health System in Gainesville, FL. After his residency, Dr. Smith completed a postdoctoral fellowship in Family Medicine during which time he participated in the Advanced Postgraduate Program in Clinical Investigation (APPCI) and concurrently completed the requirements for a Master of Public Health. Dr. Smith joined the faculty at the University of Colorado in 2011. He returned to the University of Florida in 2014.
Dr. Smith’s research is in the area of cardiovascular pharmacotherapy and hypertension and is funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. He is a member of the American Heart Association, American College of Cardiology, American College of Clinical Pharmacy, the American Association of Colleges of Pharmacy and the International Society for Pharmacoepidemiology. He also serves in several leadership roles nationally, including on the Examination Committee for the American Society of Hypertension Specialists’ Program (ASHSP) Certified Hypertension Clinician program, in several initiatives through the American Heart Association Hypertension Council, on the Board of Directors for the Consortium for Southeastern Hypertension Control, and as a founding member of the CDC’s National Hypertension Control Roundtable.
Dr. Smith also co-directs the UF Family Medicine Pharmacy Fellowship (https://ptr.pharmacy.ufl.edu/uf-family-medicine-pharmacy-fellowship/).
Dr. Smith teaches Pharmacy & Population Health in the first year of the Pharm.D. curriculum.
Danxin Wang M.D., Ph.D.
Dr. Wang received her MD degree from Fudan University Medical School and her Ph.D from the Academy of Military Medical Science in Beijing. She did postdoctoral training at the University of California San Francisco. She was a Research Assistant Professor at Ohio State University, Department of Cancer Biology and Genetics and Associate Director of Center for Pharmacogenomics prior to joining the University of Florida.
Dr. Wang’s research interests are the discovery of genetic biomarkers for personalized drug therapy. She has discovered many functional regulatory variants in genes related to drug therapy in the areas of cardiovascular diseases, mental diseases and drug dependence. Some of these functional variants are currently included in biomarker testing panels to predict drug response.
Funded by NIH R01 award, “Expression genetics of CYP3A drug metabolizing enzymes”, Dr. Wang’s current research is to understand factors controlling the expression of CYP3A, the main drug metabolizing enzyme in the liver. Using recently developed cutting edge functional genetics/genomics approaches, the research will focus on understanding what genetic, epigenetic and non-genetic factors may contribute to CYP3A variability, with the goal to identify biomarker predicting CYP3A enzyme activity for personalized therapy of nearly 50% of currently used medications.
Dr. Wang has served as an Associate Editor of “European Journal of Pharmaceutical Sciences” and was on editorial Board of “Journal of Pharmacogenomics and Pharmacoproteomics”. She has also served as grant reviewer for NIH.